# MiCardia Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/micardia

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.micardia.com
- Total disclosed funding: $9M
- Latest round: Series B (Sep 21, 2006)
- Investors on record: 4

## About

MiCardia Corporation is a domain name trading company focused on secure transactions and customer-centric services, specializing in premium domain acquisitions.MiCardia Corporation is engaged in the domain name trading business, offering a marketplace for buying and leasing domain names. The company is headquartered in Irvine, US. It has raised a total of USD 4.4 mn, including a recent VENTURE DEBT round of USD 3.69 mn in April 2013. The company has been involved in 7 different deals to date.MiCardia.com specializes in the buying and leasing of domain names, primarily facilitating secure and efficient transactions for clients. The core offering includes the sale of premium domain names, such as MiCardIa.com, which is available for direct purchase at USD 2,695. The services aim to simplify the domain acquisition process and provide features like free transaction support and secure payment options, with a target market of businesses, entrepreneurs, and individuals seeking a robust online presence in North America and Europe.MiCardia.com operates on a transactional revenue model, deriving income primarily from the sale of domain names. The flagship offering, MiCardIa.com, is priced at USD 2,695. Revenue also may come from additional services like domain leasing or premium support, although specific details are not publicly disclosed. The company's model focuses on direct-to-consumer sales in the digital marketplace.MiCardia Corporation plans to utilize the recent funding of USD 3.69 mn to enhance its product offerings and improve market reach. Specific upcoming products have not been detailed, but the company is looking to expand its footprint in North American and European markets by the end of 2014. The focus is on streamlining the transaction process further and possibly introducing new features for customers.

## Funding rounds

- Series B, Sep 21, 2006, $9M — HBM Partners, Japan Asia Investment Company, BioStar Capital, MedFocus Funds

## Investors

- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B
- Japan Asia Investment Company (https://capitalatlas.ai/funds/japan-asia-investment-company) — Series B
- BioStar Capital (https://capitalatlas.ai/funds/biostar-capital) — Series B
- MedFocus Funds (https://capitalatlas.ai/funds/medfocus-funds) — Series B